Schedule 13D ownership disclosure

Vera Therapeutics Inc

Security class unavailable · CUSIP: 92337R101

Event date: 2021-05-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,960,231
Percent of class
14.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-21-000728
Form type
SC 13D
Filer
Abingworth LLP
CIK
CIK 1397144
Filed
May 24, 2021
Reporting period
May 18, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub